ICTU is currently involved in three respiratory trials led by Investigators at Imperial College and the Royal Brompton and Harefield NHS Foundation Trust. The areas of research are: asthma, cystic fibrosis and interstitial lung disease.
AZALEA: A Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Oral Azithromycin (500 Mg OD) as a Supplement to Standard Care for Adult Patients with Acute Exacerbations of Asthma.
This trial is looking at the use of the antibiotic azithromycin in treatment of patients following acute asthma attacks to show whether or not azithromycin in as an adjunct to standard care leads to quicker recovery from the exacerbation. The trial also examines the mechanism for azithromyci’s potential benefit i.e. - if it is having an anti-bacterial and/or anti-viral effect. Recruitment and follow up have completed for the study.